Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-023955
Filing Date
2024-09-25
Accepted
2024-09-25 16:43:18
Documents
2
Period of Report
2024-09-25

Document Format Files

Seq Description Document Type Size
1 form3-09252024_080914.html 3  
1 form3-09252024_080914.xml 3 4515
2 ex24-09252024_080916.htm EX-24 6937
  Complete submission text file 0001415889-24-023955.txt   12859
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Issuer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOAGE LABS, INC. 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address
Barton Shane (Reporting) CIK: 0001836297 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42279 | Film No.: 241325194